These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 19690635)

  • 1. A list of candidate cancer biomarkers for targeted proteomics.
    Polanski M; Anderson NL
    Biomark Insights; 2007 Feb; 1():1-48. PubMed ID: 19690635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer biomarkers: surviving the journey from bench to bedside.
    Rhea JM; Molinaro RJ
    MLO Med Lab Obs; 2011 Mar; 43(3):10-2, 16, 18; quiz 20, 22. PubMed ID: 21446576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
    Hüttenhain R; Choi M; Martin de la Fuente L; Oehl K; Chang CY; Zimmermann AK; Malander S; Olsson H; Surinova S; Clough T; Heinzelmann-Schwarz V; Wild PJ; Dinulescu DM; Niméus E; Vitek O; Aebersold R
    Mol Cell Proteomics; 2019 Sep; 18(9):1836-1850. PubMed ID: 31289117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
    Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
    J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine.
    Duriez E; Masselon CD; Mesmin C; Court M; Demeure K; Allory Y; Malats N; Matondo M; Radvanyi F; Garin J; Domon B
    J Proteome Res; 2017 Apr; 16(4):1617-1631. PubMed ID: 28287737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hypothesis-directed approach to the targeted development of a multiplexed proteomic biomarker assay for cancer.
    Mackay EM; Koppel J; Das P; Woo J; Schriemer DC; Bathe OF
    Cancer Inform; 2015; 14():65-70. PubMed ID: 26023280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma.
    Kennedy JJ; Whiteaker JR; Ivey RG; Burian A; Chowdhury S; Tsai CF; Liu T; Lin C; Murillo OD; Lundeen RA; Jones LA; Gafken PR; Longton G; Rodland KD; Skates SJ; Landua J; Wang P; Lewis MT; Paulovich AG
    Anal Chem; 2022 Jul; 94(27):9540-9547. PubMed ID: 35767427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis to select cancer candidate biomarkers to targeted validation.
    Kawahara R; Meirelles GV; Heberle H; Domingues RR; Granato DC; Yokoo S; Canevarolo RR; Winck FV; Ribeiro AC; Brandão TB; Filgueiras PR; Cruz KS; Barbuto JA; Poppi RJ; Minghim R; Telles GP; Fonseca FP; Fox JW; Santos-Silva AR; Coletta RD; Sherman NE; Paes Leme AF
    Oncotarget; 2015 Dec; 6(41):43635-52. PubMed ID: 26540631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic Cancer.
    Vandenbrouck Y; Christiany D; Combes F; Loux V; Brun V
    Proteomics; 2019 Nov; 19(21-22):e1800489. PubMed ID: 31538697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of systemic treatment response in people with psoriasis: a scoping review.
    Corbett M; Ramessur R; Marshall D; Acencio ML; Ostaszewski M; Barbosa IA; Dand N; Di Meglio P; Haddad S; Jensen AHM; Koopmann W; Mahil SK; Rahmatulla S; Rastrick J; Saklatvala J; Weidinger S; Wright K; Eyerich K; Barker JN; Ndlovu M; Conrad C; Skov L; Smith CH;
    Br J Dermatol; 2022 Oct; 187(4):494-506. PubMed ID: 35606928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Proteomics on the Basis of Discovery of Predictive Biomarkers of Response to Androgen Deprivation Therapy in Advanced Prostate Cancer.
    Kohli M; Oberg AL; Mahoney DW; Riska SM; Sherwood R; Zhang Y; Zenka RM; Sahasrabudhe D; Qin R; Zhang S
    Clin Genitourin Cancer; 2019 Aug; 17(4):248-253.e7. PubMed ID: 31103340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.
    Ray S; Patel SK; Kumar V; Damahe J; Srivastava S
    Proteomics Clin Appl; 2014 Feb; 8(1-2):53-72. PubMed ID: 24293340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of pathway biomarkers from coupled proteomics and systems biology methods.
    Zhang F; Chen JY
    BMC Genomics; 2010 Nov; 11 Suppl 2(Suppl 2):S12. PubMed ID: 21047379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted proteomics: a bridge between discovery and validation.
    Harlan R; Zhang H
    Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
    de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
    J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.